YOUNGSVILLE, N.C.--(BUSINESS WIRE)--Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, announced that Bill Butterfield, executive vice president and chief technology officer, will be presenting a technical paper at this year’s Tissue World Barcelona on March 17, 2015.
Mr. Butterfield will be presenting a paper titled “Improving Tissue Machine Performance With New Fabric, Felt and Roll Cover Technology” at 14:00 CET, as part of the Yankee Dryer Optimization session.
He will also be previewing the company’s newly developed SMART® Technology for tissue suction roll applications. With well over 550 SMART Technology installations worldwide on paper, packaging, and other industrial machines, Xerium has now included new functionality on vacuum applications providing tissue makers with better diagnostics and performance analysis for process optimization.
“Our customers have been requesting this functionality for years and we are delighted to now make it available to the global tissue market,” said Mr. Butterfield. “SMART Technology is already generating very unique insights for our customers and providing correlations in vacuum levels, profile, rolls and cover dynamics, and machine clothing that was previously unattainable.”
Xerium Technologies, Inc. (NYSE:XRM) is a leading global provider of industrial consumable products and services. Xerium utilizes a broad portfolio of patented and proprietary technologies to provide customers with tailored solutions and products integral to production, all designed to optimize performance and reduce operational costs. Xerium has 26 manufacturing facilities in 12 countries, 2 new plants under construction in 2 countries and employs approximately 3,100 employees.
This press release contains forward-looking statements. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “goals,” variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Actual results may differ materially from these forward-looking statements and estimates as a result of various important factors, including, without limitation, the factors discussed in our annual report on Form 10-K for the fiscal year ended December 31, 2014, which is on file with the SEC and is available in the investor relations section of our website at www.xerium.com. Any forward-looking statements are as of the date hereof, and we assume no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise, except as may be required by law.